Mcdonald Partners LLC Biogen Inc. Transaction History

Mcdonald Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$282.99 - $369.05 $200,073 - $260,918	-707 Closed	0 $0
Q2 2021 Nov 24, 2021	SELL	$259.0 - $414.71 $27,195 - $43,544	-105 Reduced 12.93%	707 $245,000
Q2 2021 Jul 23, 2021	BUY	$259.0 - $414.71 $2,590 - $4,147	10 Added 1.25%	812 $281,000
Q1 2021 Nov 24, 2021	SELL	$242.95 - $284.63 $31,583 - $37,001	-130 Reduced 13.95%	802 $224,000
Q1 2021 Apr 15, 2021	BUY	$242.95 - $284.63 $226,429 - $265,275	932 New	932 $261,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Mcdonald Partners LLC with notifications on news.